根据提供的文献内容，我将按照要求提取并结构化信息。以下是提取的信息，并以JSON格式呈现：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.89A>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "C",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutation"
                },
                {
                    "HGVS": "NM_000345.4:c.137G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "E46K mutation"
                },
                {
                    "HGVS": "NM_000345.4:c.158T>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "T",
                        "alt": "C",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T mutation"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson Disease",
        "MONDO": "MONDO:0005338"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Recombinant α-synuclein",
                "Description": "Recombinant human wild-type and mutant α-synuclein were expressed in Escherichia coli BL21(DE3) cells and purified."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Accelerates fibrillization",
                    "Result Description": "A30P mutant fibrils accelerated the nucleation-dependent fibrillization of wild-type α-synuclein."
                },
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Promotes fibrillization",
                    "Result Description": "E46K mutant fibrils promoted fibrillization of wild-type α-synuclein."
                },
                {
                    "Variant": "NM_000345.4:c.158T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Promotes fibrillization",
                    "Result Description": "A53T mutant fibrils promoted fibrillization of wild-type α-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results are expressed as means ± S.E. of three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type α-synuclein fibrils were used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Monomeric α-synuclein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Unpaired Student's t test."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Fibrillization observed within 6 days.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Fibrillization observed within 1.5 days.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Fibrils and seeds",
                "Material Name": "α-synuclein fibrils and seeds",
                "Description": "Fibrils and seeds were observed by electron microscopy."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Increased shedding of fragments",
                    "Result Description": "A30P fibrils exhibited higher levels of fragment shedding compared to wild-type fibrils."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results are expressed as means ± S.E. of three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type α-synuclein fibrils were used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Monomeric α-synuclein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Unpaired Student's t test."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Long fibrils observed.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Short fibrils and fragments observed.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blot Assay",
            "Material used": {
                "Material Source": "Fibrils and seeds",
                "Material Name": "α-synuclein fibrils and seeds",
                "Description": "Equal amounts of serially diluted fibrils and seeds were spotted onto polyvinylidene difluoride membrane."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Different conformation",
                    "Result Description": "A30P fibrils showed a distinct conformation from wild-type fibrils."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results are expressed as means ± S.E. of three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type α-synuclein fibrils were used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Monomeric α-synuclein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Unpaired Student's t test."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Strong immunoreactivity with syn1–10 and syn75–91.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Weak immunoreactivity with syn75–91 and strong immunoreactivity with syn1–10.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释
1. **Variants Include**：提取了文献中提到的所有突变体，并标准化了HGVS命名法。每个突变体的详细信息包括基因名称、转录本编号、核苷酸和氨基酸变化及其在文献中的描述。
2. **Described Disease**：确定了文献研究的疾病为帕金森病（Parkinson Disease），并从MONDO数据库中检索了对应的术语。
3. **Experiment Method**：列出了文献中提到的所有实验方法，并提取了每种方法的详细信息，包括材料来源、读出类型、结果描述、实验重复次数、对照设置、统计分析方法以及正常和异常结果的阈值。还判断了这些实验方法是否通常用于研究该疾病。

希望这些信息符合您的需求。如果有任何进一步的问题或需要调整的地方，请随时告知。